Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
—·2d
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.
TickersGLPChannelsoil_gas, stocksCountriesusaCategoriesmarket-general
Open original source ↗Published
6/8/2026, 2:30:37 PM
Fetched
6/8/2026, 3:07:20 PM
Confidence
60 / 100
Relevance
35 / 100
Trust
—
Language
en